Soluble neprilysin and survival in critically ill patients

BACKGROUND: Critically ill patients admitted to an intensive care unit (ICU) exhibit a high mortality rate irrespective of the initial cause of hospitalization. Neprilysin, a neutral endopeptidase degrading an array of vasoactive peptides became a drug target within the treatment of heart failure wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenz, Max, Krychtiuk, Konstantin A., Brekalo, Mira, Draxler, Dominik F., Pavo, Noemi, Hengstenberg, Christian, Huber, Kurt, Hülsmann, Martin, Heinz, Gottfried, Wojta, Johann, Speidl, Walter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934932/
https://www.ncbi.nlm.nih.gov/pubmed/35040286
http://dx.doi.org/10.1002/ehf2.13787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934932/
https://www.ncbi.nlm.nih.gov/pubmed/35040286
http://dx.doi.org/10.1002/ehf2.13787

Ejemplares similares